Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
docetaxel oral/ritonavir (ModraDoc006/r)
i
Other names:
ModraDoc006/r, ModraDoc 006/r, ModraDoc 006
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
News
Trials
Company:
Modra Pharma
Drug class:
Tubulin polymerization promoter, Microtubule stabilizer, Protease inhibitor
Related drugs:
‹
carboplatin (208)
paclitaxel (178)
docetaxel (163)
TH 1902 (8)
docetaxel nanoformulation (0)
docetaxel polymeric micelle (0)
CPO100 (0)
LE-DT (0)
STK-01 (0)
BAY86-5302 (0)
UTD1 (0)
EPO 906 (0)
nelfinavir (1)
ritonavir (0)
carboplatin (208)
paclitaxel (178)
docetaxel (163)
TH 1902 (8)
docetaxel nanoformulation (0)
docetaxel polymeric micelle (0)
CPO100 (0)
LE-DT (0)
STK-01 (0)
BAY86-5302 (0)
UTD1 (0)
EPO 906 (0)
nelfinavir (1)
ritonavir (0)
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login